Model Video Activity in Anatomy Education

August 29, 2024 updated by: NAkbayturk, Giresun University

Investigation of the Effect of Model Video Activity on Medical Faculty Students' Anatomy Education

During Anatomy education and training at medical school; In addition to theoretical lecture presentations, visual alternative methods such as videos can be used to better understand, learn and keep in mind anatomical structures, to help reinforce knowledge and to increase students' motivation in anatomy lessons. Model videos can be an alternative to visual anatomy education in order to provide a better understanding of the subjects so that people can watch model videos wherever and whenever they want, in addition to the theoretical lesson.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The study aims to evaluate the effect of using model video activity on anatomy education in first-year medical faculty students. This study was planned to be conducted in a randomized controlled trial in a pre-test-post-test design to determine the effect of model video activity in anatomy education on the anatomy education of medical faculty students.The population of the research will be first-year students at Giresun University Faculty of Medicine, and the sample will be students who agree to participate in the research. Students who agreed to participate in the study were divided into experimental and control groups using the randomization method. Participants' consent to participate in the study was obtained by ticking the 'Volunteer consent form' and 'I want to participate in the study' box on the first page of the survey. Students who accept the research will fill out the "Introductory Characteristics of Students Form". After the anatomy course topic is explained in class, students will answer the theoretical questions about the subjects and the pre-test online via a Google Forms survey. Anatomy model videos prepared by the researchers for the experimental group students will be uploaded to Google Drive and sent via link. Students will be asked to log in from their computer or mobile phone and watch anatomy model videos whenever and wherever they want. Students in the experimental group will answer the final test after studying for a week and watching videos on Facial Muscles, Neck Anatomy and Muscles (Anterior Side Region Muscles and Triangles), Forearm Anterior Region Muscles, Forearm Posterior Region Muscles and Hand Muscles.

No application will be made to the control group and their training will continue only with the traditional method. Control group students will fill out the theoretical questions test again on the topics "Facial Muscles, Neck Anatomy and Muscles (Anterior Side Region Muscles and Triangles), Forearm Anterior Region Muscles, Forearm Posterior Region Muscles and Hand Muscles".

After the experimental group application is completed and all data is received, anatomy model videos will be shared with the control group students. Students will be asked to fill out the 'Anatomy Model Video Activity Feedback Form'.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
148

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Giresun, Turkey
        • Giresun University, Faculty of Medicine, Department of Anatomy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • First year students of Giresun University Faculty of Medicine
  • Students who volunteered to participate in the study

Exclusion Criteria:

  • Giresun University Faculty of Medicine 2nd, 3rd, 4th, 5th and 6th grade students
  • Students who do not have a smartphone or computer and do not have internet access
  • Students who did not volunteer to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: experimental group
After the anatomy course topic is explained in class, students will answer the theoretical questions about the subjects and the pre-test online via a Google Forms survey. Anatomy model videos prepared by the researchers for the experimental group students will be uploaded to Google Drive and sent via link. Students will be asked to log in from their computer or mobile phone and watch anatomy model videos whenever and wherever they want. Students in the experimental group will answer the final test after studying for a week and watching videos on Facial Muscles, Neck Anatomy and Muscles (Anterior Side Region Muscles and Triangles), Forearm Anterior Region Muscles, Forearm Posterior Region Muscles and Hand Muscles.
Other: experimental group
. Anatomy model videos prepared by the researchers for the experimental group students will be uploaded to Google Drive and sent via link. Students will be asked to log in from their computer or mobile phone and watch anatomy model videos whenever and wherever they want
No Intervention: control group
No application will be made to the control group and their training will continue only with the traditional method. Control group students will fill out the theoretical questions test again on the topics "Facial Muscles, Neck Anatomy and Muscles (Anterior Side Region Muscles and Triangles), Forearm Anterior Region Muscles, Forearm Posterior Region Muscles and Hand Muscles

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The effects of model video activity in anatomy education on the anatomy education of medical faculty students were measured with the 'Anatomy theoretical questions test' prepared by the researchers.
Time Frame: The duration of watching anatomy model videos for each subject is 1 week. The time to complete the 'Anatomy theoretical questions test' pre-tests and post-tests is 1 week each.
A randomized controlled study with pre-test-post-test design with experimental and control groups. 'Anatomy theoretical questions test' prepared for pre-test and post-test was given to students before and after watching anatomy model videos. 'Anatomy theoretical questions test' prepared by researchers consists of 25 questions, each with five options.
The duration of watching anatomy model videos for each subject is 1 week. The time to complete the 'Anatomy theoretical questions test' pre-tests and post-tests is 1 week each.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Giresun University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 4, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 17, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 25, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 9, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 17, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 18, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 30, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 29, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • GRU-ANA-NA-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Education

Clinical Trials on experimental group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings